PIK3CA and breast cancer: These alterations are in line with a large-scale analysis of 6338 BC samples reporting five recurrent PIK3CA alterations, H1047R (35 %), E545K (17 %), E542K (11 %), N345K (6 %), and H1047L (4 %), accounting for 73 % of all alterations [52].